Fmr LLC Increases Position in Core Laboratories Inc. (NYSE:CLB)

Fmr LLC raised its holdings in Core Laboratories Inc. (NYSE:CLB) by 182.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 17,057 shares of the oil and gas company’s stock after acquiring an additional 11,028 shares during the period. Fmr LLC’s holdings in Core Laboratories were worth $316,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Headlands Technologies LLC purchased a new stake in shares of Core Laboratories in the second quarter valued at approximately $36,000. nVerses Capital LLC purchased a new position in shares of Core Laboratories during the 3rd quarter worth $48,000. GAMMA Investing LLC boosted its position in shares of Core Laboratories by 33.0% during the 3rd quarter. GAMMA Investing LLC now owns 5,885 shares of the oil and gas company’s stock valued at $109,000 after acquiring an additional 1,460 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in shares of Core Laboratories by 11.9% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company’s stock valued at $114,000 after acquiring an additional 600 shares during the last quarter. Finally, Signaturefd LLC grew its holdings in shares of Core Laboratories by 12.8% in the second quarter. Signaturefd LLC now owns 6,776 shares of the oil and gas company’s stock valued at $137,000 after purchasing an additional 767 shares during the period. 97.81% of the stock is owned by hedge funds and other institutional investors.

Core Laboratories Trading Down 4.4 %

NYSE CLB opened at $16.85 on Friday. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.48 and a quick ratio of 1.79. The stock has a market capitalization of $791.11 million, a P/E ratio of 25.92, a PEG ratio of 1.36 and a beta of 2.35. The firm’s 50-day moving average is $19.62 and its two-hundred day moving average is $19.67. Core Laboratories Inc. has a 12 month low of $13.82 and a 12 month high of $25.13.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.04. The business had revenue of $134.40 million for the quarter, compared to the consensus estimate of $134.16 million. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The business’s revenue was up 7.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.22 EPS. On average, sell-side analysts anticipate that Core Laboratories Inc. will post 0.8 earnings per share for the current year.

Core Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.24%. The ex-dividend date of this dividend was Monday, November 4th. Core Laboratories’s dividend payout ratio (DPR) is 6.15%.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Citigroup reduced their price target on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a research report on Thursday, October 31st. Two research analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. Based on data from MarketBeat.com, Core Laboratories has a consensus rating of “Hold” and an average target price of $17.00.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.